S. Jazayeri

Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (<scp>JUNCTURE</scp>)

C. Paul, J.‐P. Lacour, L. Tedremets et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 277 citations

Medicine, Dermatology, Pharmacotherapy +17

Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled <scp>TRANSFIGURE</scp> trial

Kristian Reich, John Sullivan, Petr Arenberger et al. · British Journal of Dermatology · 2018 · 101 citations

Medicine, Dermatology, Pharmacotherapy +14

Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5‐year results from the randomized placebo‐controlled TRANSFIGURE study*

Kristian Reich, John Sullivan, Petr Arenberger et al. · British Journal of Dermatology · 2020 · 72 citations

Medicine, Dermatology, Pharmacotherapy +17

Secukinumab administration by autoinjector maintains reduction of plaque psoriasis severity over 52 weeks: results of the randomized controlled <scp>JUNCTURE</scp> trial

J.‐P. Lacour, C. Paul, S. Jazayeri et al. · Journal of the European Academy of Dermatology and Venereology · 2017 · 57 citations

Medicine, Dermatology, Pharmacotherapy +16

Similar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO study

Alan Menter, Petr Arenberger, Sigrid Balser et al. · Expert Opinion on Biological Therapy · 2020 · 20 citations · Full text

Medicine, Dermatology, Pharmacology +12